From: The Honorable Scott H. Peters
Sent By:

Date: 5/5/2016

Dear Colleague:
By now you should have received an invitation to a congressional briefing on the value of biomedical innovation, hosted in cooperation with the Congressional Life Science Caucus on Thursday, May 12th at 10am in HVC-200 (Capitol Visitor Center).  Attendees will learn about the importance of biomedical innovation, from new treatments, diagnostic tools, medical and digital technologies, and therapies and cures.
Participants will hear from the following experts:
  • Joseph Panetta, President and Chief Executive Officer, Biocom
  • Christopher Molineaux, President and Chief Executive Officer, Pennsylvania Bio
  • Don May, Executive Vice President for Payment and Health Care Delivery Policy, AdvaMed
  • Eric Gasho, Vice President, National Health Council
Biomedical innovation – researching and developing new treatments and cures for the world’s most dreaded diseases – is a highly complex and long undertaking, which holds the promise of helping patients around the world live longer, with less pain and more independence. Advances in biomedical innovation not only save lives and improve the human condition, but also save money within the health care system and drive America’s workforce and economy. If you are interested in attending this briefing, please RSVP to Laure Fabrega at
The Life Science Caucus is an informal and bipartisan group dedicated to educating Members and staff on all major life science sectors, including biotechnology, diagnostic and medical device, digital health, agriculture, and bio-renewable energy. We encourage all Members and their staff to attend this important briefing.
If you have any questions about the caucus, please do not hesitate to contact Anthony Nguyen from the office of Congressman Scott Peters (CA-52) at (202) 225-0508 or by email at or Molly McDonnell from the office of Congressman
Leonard Lance (NJ-07) at (202) 225-5361 or by email at


Scott H. Peters

Leonard Lance